Dow Climbs Amid Hopes for Hormuz Deal
episodeTranscript
jump: chapters · speakers · find in transcriptTranscript
Transcript generated automatically by AI and may contain errors.
What’s the overall market outlook and why did the Dow lead today?
AI can transform a single customer experience. What's hard is making it work everywhere, every interaction, every channel, across a global enterprise. That's the difference with NICE. One platform that connects agencagents, human agents, and customer intelligence across the entire customer experience. So instead of managing disconnected tools, you're delivering experiences that get smarter with every interaction. NICE, the proven CXAI leader.
How are diplomatic talks between the U.S. and Iran influencing crude‑oil prices?
Learn more at Nice.com.
Here's your closing bell brief for Friday, September 25th. I'm Julie Chang for the Wall Street Journal. U.S. stocks gained ground today as a global bond sell-off paused. The Dow led the market, rising nearly 1%.
What’s driving the recent surge in Akamai and the $11.6 billion cloud deal?
The SP 500 and the Nasdaq each added about half a percent. Crude oil prices fell following reports of diplomatic talks between the US and Iran and hopes for a deal to To reopen the Strait of Hormuz. Meanwhile, slightly higher consumer sentiment figures out today kept inflation concerns in focus. Among individual stocks, shares of Akamai Technologies closed up over 3%. The surge followed news of an $11.6 billion cloud services deal between Akamai and Anthropic.
Why did Nanexa’s stock more than double after Novo Nordisk’s drug‑delivery deal?
The Nexus stock more than doubled today after Nova Nordisk agreed to pay up to the city. one point three billion dollars for the Swedish company's drug delivery technology. and shares of people closed up over eleven percent, after the journal reported that People is a potential acquisition target for casino operator MGM Resorts. Heads up, an artificial intelligence tool helped us make this episode by creating summaries that were based on WSJ reporting and then reviewed and adapted by an editor. We'll have more coverage of the day's news on the WSJ's What's News podcast. Listen and subscribe wherever you get your podcasts.
How does Medline’s 60‑year history support its role as a leading medical‑supply provider?
Savvy investors understand consistent growth is built on scale, resilience, and trust. For more than 60 years, Medline has proven this, driven by an unrelenting commitment to their customers. Today, Medline is proudly NASDAQ listed and is the largest provider of medical surgical products and supply chain solutions serving all points of care. With a focus on what healthcare needs next, Medline strives to make healthcare run better. See how Medline is woven throughout healthcare and learn more at medline dot com.
No segments match your search.
Select any passage to copy it with its citation or turn it into a shareable card.
Chapters
5 chapters
1
What’s the overall market outlook and why did the Dow lead today?
0:00–0:28
2
How are diplomatic talks between the U.S. and Iran influencing crude‑oil prices?
0:28–0:47
3
What’s driving the recent surge in Akamai and the $11.6 billion cloud deal?
0:47–1:18
4
Why did Nanexa’s stock more than double after Novo Nordisk’s drug‑delivery deal?
1:18–1:57
5
How does Medline’s 60‑year history support its role as a leading medical‑supply provider?
1:57–2:26